全文获取类型
收费全文 | 5918篇 |
免费 | 376篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 115篇 |
妇产科学 | 136篇 |
基础医学 | 913篇 |
口腔科学 | 91篇 |
临床医学 | 477篇 |
内科学 | 1530篇 |
皮肤病学 | 96篇 |
神经病学 | 643篇 |
特种医学 | 159篇 |
外科学 | 600篇 |
综合类 | 13篇 |
一般理论 | 3篇 |
预防医学 | 329篇 |
眼科学 | 82篇 |
药学 | 453篇 |
中国医学 | 9篇 |
肿瘤学 | 644篇 |
出版年
2024年 | 5篇 |
2023年 | 58篇 |
2022年 | 125篇 |
2021年 | 195篇 |
2020年 | 119篇 |
2019年 | 162篇 |
2018年 | 165篇 |
2017年 | 121篇 |
2016年 | 171篇 |
2015年 | 178篇 |
2014年 | 207篇 |
2013年 | 304篇 |
2012年 | 444篇 |
2011年 | 449篇 |
2010年 | 259篇 |
2009年 | 214篇 |
2008年 | 403篇 |
2007年 | 405篇 |
2006年 | 355篇 |
2005年 | 376篇 |
2004年 | 362篇 |
2003年 | 296篇 |
2002年 | 280篇 |
2001年 | 63篇 |
2000年 | 56篇 |
1999年 | 63篇 |
1998年 | 52篇 |
1997年 | 56篇 |
1996年 | 36篇 |
1995年 | 40篇 |
1994年 | 27篇 |
1993年 | 20篇 |
1992年 | 31篇 |
1991年 | 23篇 |
1990年 | 20篇 |
1989年 | 30篇 |
1988年 | 24篇 |
1987年 | 22篇 |
1986年 | 26篇 |
1985年 | 23篇 |
1984年 | 17篇 |
1983年 | 9篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 3篇 |
1976年 | 4篇 |
1972年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有6342条查询结果,搜索用时 0 毫秒
81.
Lyra Razanadrakoto Fran?oise Cormier Vanessa Laurienté Elisabetta Dondi Laura Gardano Shulamit Katzav Lionel Guittat Nadine Varin-Blank 《Oncotarget》2015,6(4):2524-2538
Vav family members function as remarkable scaffold proteins that exhibit both GDP/GTP exchange activity for Rho/Rac GTPases and numerous protein-protein interactions via three adaptor Src-homology domains. The exchange activity is under the unique regulation by phosphorylation of tyrosine residues hidden by intra-molecular interactions. Deletion of the autoinhibitory N-terminal region results in an oncogenic protein, onco-Vav, leading to a potent activation of Rac GTPases whereas the proto-oncogene barely leads to transformation. Substitution of conserved residues of the SH2-SH3 adaptor region in onco-Vav reverses oncogenicity. While a unique substitution D797N did not affect transformation induced by onco-Vav, we demonstrate that this single substitution leads to transformation in the Vav1 proto-oncogene highlighting the pivotal role of the adaptor region. Moreover, we identified the cell junction protein β-catenin as a new Vav1 interacting partner. We show that the oncogenicity of activated Vav1 proto-oncogene is associated with a non-degradative phosphorylation of β-catenin at residues important for its functions and its redistribution along the cell membrane in fibroblasts. In addition, a similar interaction is evidenced in epithelial lung cancer cells expressing ectopically Vav1. In these cells, Vav1 is also involved in the modulation of β-catenin phosphorylation. Altogether, our data highlight that only a single mutation in the proto-oncogene Vav1 enhances tumorigenicity. 相似文献
82.
83.
Cremildo João Baptista Inês Dourado Tarcísio Matos de Andrade Sandra Brignol Neilane Bertoni Francisco Inácio Bastos The Brazilian Multicity Study Group on Drug Misuse 《AIDS and behavior》2018,22(7):2089-2103
Brazil has a concentrated HIV epidemic among key populations. In 2009, the Ministry of Health conducted a survey in 10 Brazilian cities aiming to estimate HIV prevalence, knowledge, and associated risk behaviors of polysubstance users (PSU). Using Respondent Driven Sampling (RDS), 3449 PSU were recruited, answered an Audio-Computer Self Assisted Interview (ACASI) and were tested for HIV and syphilis. Analyses were weighted by individual’s social network size generated on RDSAT. Pooled HIV prevalence was 5.8% but varied across cities. Most PSU were male, non-white, without income, unemployed, with low levels of education. Overall, 12.0% used injectable drugs, 48.7% had sex with occasional partners and 46.4% engaged in commercial sex. A majority received free condoms (71.4%) but 76.7% exhibited inconsistent condom use. Findings can support policies aiming to improve health care and preventive interventions tailored to this population that remains at high risk of acquiring and transmitting HIV/STI in multiple scenarios. 相似文献
84.
A great bulk of evidence supports the concept that regular exercise training can reduce the incidence of coronary events and increase survival chances after myocardial infarction. These exercise-induced beneficial effects on the myocardium are reached by means of the reduction of several risk factors relating to cardiovascular disease, such as high cholesterol, hypertension, obesity etc. Furthermore, it has been demonstrated that exercise can reproduce the “ischemic preconditioning” (IP), which refers to the capacity of short periods of ischemia to render the myocardium more resistant to subsequent ischemic insult and to limit infarct size during prolonged ischemia. However, IP is a complex phenomenon which, along with infarct size reduction, can also provide protection against arrhythmia and myocardial stunning due to ischemia-reperfusion. Several clues demonstrate that preconditioning may be directly induced by exercise, thus inducing a protective phenotype at the heart level without the necessity of causing ischemia. Exercise appears to act as a physiological stress that induces beneficial myocardial adaptive responses at cellular level. The purpose of the present paper is to review the latest data on the role played by exercise in triggering myocardial preconditioning. 相似文献
85.
Michela Palleschi Roberta Maltoni Eleonora Barzotti Elisabetta Melegari Annalisa Curcio Lorenzo Cecconetto Samanta Sarti Silvia Manunta Andrea Rocca 《World Journal of Clinical Cases》2020,8(3):517-521
BACKGROUND Pathological complete response(pCR) is rare in hormone receptor-positive(HR+)HER2-negative breast cancer(BC) treated with either endocrine therapy(ET) or chemotherapy. Radical resection of locoregional relapse, although potentially curative in some cases, is challenging when the tumor invades critical structures.The oral cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with ET has obtained a significant increase in objective response rates and progression-free survival in patients with advanced BC and is now being evaluated in the neoadjuvant setting. We present a clinical case of a patient with an inoperable locoregional relapse of HR+ HER2-negative BC who experienced p CR after treatment with palbociclib.CASE SUMMARY We report the clinical case of a 60-year-old patient who presented with an inoperable locoregional relapse of HR+, HER2-negative BC 10 years after the diagnosis of the primary tumor. During a routine follow-up visit, breast magnetic resonance imaging and positron emission tomography/computed tomography revealed a 4-cm lesion in the right subclavicular region, infiltrating the chest wall and extending to the subclavian vessels, but without bone or visceral involvement. Treatment was begun with palbociclib plus letrozole, converting the disease to operability over a period of 6 mo. Surgery was performed and a p CR achieved. Of note, during treatment the patient experienced a very uncommon toxicity characterized by burning tongue and glossodynia associated with dysgeusia, paresthesia, dysesthesia, and xerostomia. A reduction in the dose of palbociclib did not provide relief and treatment with the inhibitor was thus discontinued, resolving the tongue symptoms. Laboratory exams were unremarkable. Given that this was a late relapse, the tumor was classified asendocrine-sensitive, a condition associated with high sensitivity to palbociclib.CONCLUSION This case highlights the potential of the cyclin-dependent kinase 4/6 inhibitor plus ET combination to achieve pCR in locoregional relapse of BC, enabling surgical resection of a lesion initially considered inoperable. 相似文献
86.
87.
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency,mainly for FX Friuli,matched versus 128 unaffected family members,during a long sequential observation period (23.5 years) 下载免费PDF全文
88.
Collin P Kaukinen K Vogelsang H Korponay-Szabó I Sommer R Schreier E Volta U Granito A Veronesi L Mascart F Ocmant A Ivarsson A Lagerqvist C Bürgin-Wolff A Hadziselimovic F Furlano RI Sidler MA Mulder CJ Goerres MS Mearin ML Ninaber MK Gudmand-Høyer E Fabiani E Catassi C Tidlund H Alainentalo L Mäki M 《European journal of gastroenterology & hepatology》2005,17(1):85-91
OBJECTIVE: To investigate the value of serum antitissue transglutaminase IgA antibodies (IgA-TTG) and IgA antiendomysial antibodies (IgA-EMA) in the diagnosis of coeliac disease in cohorts from different geographical areas in Europe. The setting allowed a further comparison between the antibody results and the conventional small-intestinal histology. METHODS: A total of 144 cases with coeliac disease [median age 19.5 years (range 0.9-81.4)], and 127 disease controls [median age 29.2 years (range 0.5-79.0)], were recruited, on the basis of biopsy, from 13 centres in nine countries. All biopsy specimens were re-evaluated and classified blindly a second time by two investigators. IgA-TTG were determined by ELISA with human recombinant antigen and IgA-EMA by an immunofluorescence test with human umbilical cord as antigen. RESULTS: The quality of the biopsy specimens was not acceptable in 29 (10.7%) of 271 cases and a reliable judgement could not be made, mainly due to poor orientation of the samples. The primary clinical diagnosis and the second classification of the biopsy specimens were divergent in nine cases, and one patient was initially enrolled in the wrong group. Thus, 126 coeliac patients and 106 controls, verified by biopsy, remained for final analysis. The sensitivity of IgA-TTG was 94% and IgA-EMA 89%, the specificity was 99% and 98%, respectively. CONCLUSIONS: Serum IgA-TTG measurement is effective and at least as good as IgA-EMA in the identification of coeliac disease. Due to a high percentage of poor histological specimens, the diagnosis of coeliac disease should not depend only on biopsy, but in addition the clinical picture and serology should be considered. 相似文献
89.
Piccoli M Trambaiolo P Salustri A Cerquetani E Posteraro A Pastena G Amici E Papetti F Marincola E La Carruba S Gambelli G 《Chest》2005,128(5):3413-3420
OBJECTIVES: The aim of this study was to assess the potential value of hand-carried ultrasound (HCU) devices in the diagnosis and follow-up of patients with pleural effusion (PE) after cardiac surgery. METHODS: Seventy consecutive patients were evaluated at bedside early after cardiac surgery, in the upright sitting position, using an HCU device on hospital admission and every 3 days until hospital discharge. The posterior chest wall was scanned along the paravertebral, scapular, and posterior axillary lines. For each hemithorax, an effusion index was derived as the sum of the intercostal spaces between the lower and upper limits of the PE along the lines of scanning, divided by 3. A standard chest radiograph was performed in all patients on hospital admission and at hospital discharge, and was qualitatively scored (0, absent; 1, small; 2, large PE). The findings of the HCU device and radiograph were compared using kappa statistics and the Kruskal-Wallis test. RESULTS: A chest ultrasound was feasible in all patients (mean [+/- SD] time, 5 +/- 2 min). Compared with the chest ultrasound, a physical examination showed a sensitivity of 69% and a specificity of 77%. On hospital admission, the HCU device detected a PE in 72 of 140 hemithoraxes. Agreement with the finding of the radiograph was 76% (kappa = 0.52). In 15 hemithoraxes, the HCU device revealed a PE that had not been diagnosed using the radiograph. Conversely, in 18 hemithoraxes a PE that had been diagnosed with a radiograph was not confirmed by the HCU device. The correlation between ultrasound and radiographic scores was statistically significant (p < 0.001). At hospital discharge, a PE was present in 31 of 140 hemithoraxes according to the findings of the HCU device, and in 38 of 140 hemithoraxes according to the findings of the radiograph (agreement, 78%; kappa = 0.44). CONCLUSIONS: In patients early after cardiac surgery, HCU devices allow rapid PE detection and improve the clinical diagnosis. Compared to a radiograph, this method offers the unique advantage of the bedside evaluation of patients without the need for radiation exposure. 相似文献
90.
Vignali L Saia F Manari A Santarelli A Rubboli A Varani E Piovaccari G Menozzi A Percoco G Benassi A Rusticali G Marzaroli P Guastaroba P Grilli R Maresta A Marzocchi A 《The American journal of cardiology》2008,101(7):947-952
Percutaneous revascularization of saphenous vein grafts (SVGs) remains a challenging task. Drug-eluting stents (DESs) have been shown to decrease the incidence of restenosis in de novo native coronary artery lesions. However, their clinical value in SVGs remains to be established. We compared long-term clinical outcomes of percutaneous coronary intervention with DESs and bare metal stents (BMSs) for de novo lesions in SVGs. In a large prospective, multicenter registry, 360 patients underwent stenting of a de novo lesion in SVGs using BMSs (288 patients) or DESs (72 patients). Incidence of major adverse cardiac events (MACEs), including all-cause mortality, reinfarction, and target vessel revascularization, was recorded at a 12-month follow-up. Compared with the DES group, patients receiving BMSs were more likely to be men, to have chronic renal insufficiency or higher Charlson scores, but less likely to have undergone previous percutaneous coronary intervention. Incidence of MACEs at 12-month follow-up was similar in the 2 groups (17.8% in DES group vs 20.3% in BMS group, respectively, p = 0.460). Cox regression analysis identified age, chronic renal failure, cardiogenic shock at presentation, and ostial location of stenosis as independent predictors of long-term MACEs. In conclusion, our data suggest that rates of 12-month MACEs associated with the use of DESs and BMSs are similar in patients undergoing treatment of de novo lesions in SVGs. 相似文献